Abstract

The last UK breast cancer (BC) human epidermal growth factor receptor 2 (HER2) testing guideline recommendations were published in 2015. Since then, new data and therapeutic strategies have emerged. The...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Pamela B Mangu ... John M.S Bartlett
Journal of clinical oncology : official journal of the American Society of Clinical Oncology | VOL. 31
Pamela B Mangu, et. al.Pamela B Mangu ... John M.S Bartlett
07 Oct 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Soonmyung Paik ... Antonio C Wolff
Archives of pathology & laboratory medicine | VOL. 138
Soonmyung Paik, et. al.Soonmyung Paik ... Antonio C Wolff
07 Oct 2013
The updated 2018 American Society of Clinical Oncology/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in situ hybridization groups
Yul Ri Chung ... Ji Won Woo
Human Pathology | VOL. 98
Yul Ri Chung, et. al.Yul Ri Chung ... Ji Won Woo
04 Feb 2020
Researchers find discordance between standard human epidermal growth factor receptor 2 (HER2) testing and HER2 status reported on Oncotype DX
Mary Kay Barton
CA: A Cancer Journal for Clinicians | VOL. 62
Mary Kay BartonMary Kay Barton
18 Jan 2012
View more papers

More From: Journal of Clinical Pathology

Paper Title
Journal
Date
Author
Prevalence and clinical outcomes of germline variants among patients with myeloid neoplasms
Sunisa Kongkiatkamon ... Chantana Polprasert
Journal of Clinical Pathology | VOL. -
Sunisa Kongkiatkamon, et. al.Sunisa Kongkiatkamon ... Chantana Polprasert
22 May 2024
How many mislabelled samples go unidentified? Results of a pilot study to determine the occult mislabelled sample rate
Caitlin Raymond ... Christopher Zahner
Journal of Clinical Pathology | VOL. -
Caitlin Raymond, et. al.Caitlin Raymond ... Christopher Zahner
20 May 2024
Peripheral blood smear and bone marrow findings in spontaneous tumour lysis syndrome associated with haematolymphoid malignancies
Muthu Sudalaimuthu ... Debdatta Basu
Journal of Clinical Pathology | VOL. -
Muthu Sudalaimuthu, et. al.Muthu Sudalaimuthu ... Debdatta Basu
20 May 2024
Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics
Danielle Patchell ... Stephen E Langabeer
Journal of Clinical Pathology | VOL. -
Danielle Patchell, et. al.Danielle Patchell ... Stephen E Langabeer
17 May 2024
View more papers